Related references
Note: Only part of the references are listed.IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling
Gang Xue et al.
NATURE COMMUNICATIONS (2019)
Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions
Yingying Shen et al.
NATURE COMMUNICATIONS (2019)
Th9 cytokines curb cervical cancer progression and immune evasion
Shilpa Raghuvanshi Chauhan et al.
HUMAN IMMUNOLOGY (2019)
Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors
Yong Lu et al.
CANCER CELL (2018)
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome
Marie-Andree Forget et al.
CLINICAL CANCER RESEARCH (2018)
Ectopically Expressed Membrane-bound Form of IL-9 Exerts Immune-stimulatory Effect on CT26 Colon Carcinoma Cells
Van Anh Do Thi et al.
IMMUNE NETWORK (2018)
Inhibition of squamous cancer growth in a mouse model by Staphylococcal enterotoxin B-triggered Th9 cell expansion
Bei-Ping Miao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
IL-9 and Th9 in parasite immunity
P. Licona-Limon et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer
Fa-Ping You et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Specifically differentiated T cell subset promotes tumor immunity over fatal immunity
Abdulraouf Ramadan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
IRF8-dependent molecular complexes control the Th9 transcriptional program
Etienne Humblin et al.
NATURE COMMUNICATIONS (2017)
IL-9 promotes the survival and function of human melanoma-infiltrating CD4+CD8+ double-positive T cells
Tiphaine Parrot et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Histone Deacetylase SIRT1 Negatively Regulates the Differentiation of Interleukin-9-Producing CD4+ T Cells
Yu Wang et al.
IMMUNITY (2016)
Induction of antigen-specific TH9 immunity accompanied by mast cell activation blocks tumor cell engraftment
Aws Abdul-Wahid et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
Yinghua Zhao et al.
NATURE COMMUNICATIONS (2016)
Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients
Yumi Nonomura et al.
ONCOIMMUNOLOGY (2016)
IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL
Yujiang Fang et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Mast cells as targets for immunotherapy of solid tumors
Sharon A. Oldford et al.
MOLECULAR IMMUNOLOGY (2015)
The DNA-binding inhibitor Id3 regulates IL-9 production in CD4+ T cells
Hiroko Nakatsukasa et al.
NATURE IMMUNOLOGY (2015)
Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells
Il-Kyu Kim et al.
NATURE MEDICINE (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1α-Dependent Glycolysis
Guangwei Liu et al.
CANCER RESEARCH (2014)
Inhibition of Adaptive Immunity by IL9 Can Be Disrupted to Achieve Rapid T-cell Sensitization and Rejection of Progressive Tumor Challenges
Dominique B. Hoelzinger et al.
CANCER RESEARCH (2014)
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
Frederique Vegran et al.
NATURE IMMUNOLOGY (2014)
Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers
Yong Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A Critical Role for IL-17RB Signaling in HTLV-1 Tax-Induced NF-κB Activation and T-Cell Transformation
Alfonso Lavorgna et al.
PLOS PATHOGENS (2014)
The ID proteins: master regulators of cancer stem cells and tumour aggressiveness
Anna Lasorella et al.
NATURE REVIEWS CANCER (2014)
Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma
Bo Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Utilizing TH9 cells as a novel therapeutic strategy for malignancies
Yong Lu et al.
ONCOIMMUNOLOGY (2013)
Nuclear Factor of Activated T Cells 1 (NFAT1)-induced Permissive Chromatin Modification Facilitates Nuclear Factor-κB (NF-κB)-mediated Interleukin-9 (IL-9) Transactivation
Arijita Jash et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Th9 cells promote antitumor immune responses in vivo
Yong Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Interleukin-9 receptor gene is transcriptionally regulated by nucleolin in T-Cell lymphoma cells
Yi Shang et al.
MOLECULAR CARCINOGENESIS (2012)
Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells
Rahul Purwar et al.
NATURE MEDICINE (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
Pawel Muranski et al.
IMMUNITY (2011)
Predisposition to the development of IL-9-secreting T cells in atopic infants
Weiguo Yao et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Interferon-Regulatory Factor 4 Is Essential for the Developmental Program of T Helper 9 Cells
Valerie Staudt et al.
IMMUNITY (2010)
Cellular sources and immune functions of interleukin-9
Randolph J. Noelle et al.
NATURE REVIEWS IMMUNOLOGY (2010)
T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma
Xuexian O. Yang et al.
IMMUNITY (2008)
Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset
Marc Veldhoen et al.
NATURE IMMUNOLOGY (2008)
IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3- effector T cells
Valerie Dardalhon et al.
NATURE IMMUNOLOGY (2008)
IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells
Ulla-Angela Temann et al.
INTERNATIONAL IMMUNOLOGY (2007)
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells
Lin Qiu et al.
BLOOD (2006)
Mast cells are essential intermediaries in regulatory T-cell tolerance
Li-Fan Lu et al.
NATURE (2006)
Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma
M Fischer et al.
LEUKEMIA (2003)
Multiple γc-receptor expression in adult T-cell leukemia
H Baba et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2002)
Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18
BR Lauwerys et al.
JOURNAL OF IMMUNOLOGY (2000)
Murine bone marrow-derived mast cells as potent producers of IL-9:: Costimulatory function of IL-10 and kit ligand in the presence of IL-1
M Stassen et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
